ArticleFrontiers in public health2026
Bridging the bioinformatics gap: tool selection for decentralized AMR genomic surveillance in Africa.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) poses a significant threat to public health, particularly in low- and middle-income countries where centralized genomic surveillance infrastructure is limited. To support decentralized AMR surveillance in Africa, the SeqAfrica project evaluated bioinformatics tools suitable for Oxford Nanopore Technologies sequencing data. Through two surveys and an expert elicitation workshop, the project assessed over 80 tools, focusing on usability, cost, accessibility, and AMR relevance. Graphical user interface (GUI) based tools were shortlisted for non-bioinformatician use. Terra.bio and EPI2ME emerged as leading candidates due to their user-friendly interfaces and integrated workflows. EPI2ME, which is an Oxford Nanopore Technologies tool, was favored for its offline capability, ease of use, and compatibility with local infrastructure, while Terra.bio offered strong interoperability and cloud-based scalability. The findings underscore the need for standardized, interoperable pipelines, and sustained technical support to ensure effective genomic surveillance in resource-limited settings. SeqAfrica has initiated pilot implementation and collaborative development of EPI2ME-based workflows to enhance AMR monitoring capacity across the African continent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.